Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF
CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $12.12 | 52-week high | $17.96 |
| Prev. close | $11.67 | 52-week low | $11.38 |
| Day low | $11.90 | Volume | 3,736 |
| Day high | $12.20 | Avg. volume | 3,417 |
| 50-day MA | $13.27 | Dividend yield | N/A |
| 200-day MA | $14.39 |
CNCR Stock Price Chart Interactive Chart >
Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio
The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
CNCR ETF Info
| Issuer | Range ETFs |
| Expense Ratio | 0.79% |
| Underlying Index | Range Cancer Therapeutics Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 10.06M |
| Net Asset Value (NAV) | $12.12 |
| Options? | Yes |
| Total Holdings | N/A |
CNCR Price Returns
| 1-mo | 0.25% |
| 3-mo | -18.60% |
| 6-mo | -20.58% |
| 1-year | -10.82% |
| 3-year | -37.26% |
| 5-year | -41.99% |
| YTD | -1.54% |
| 2024 | -8.61% |
| 2023 | -1.89% |
| 2022 | -42.31% |
| 2021 | -19.24% |
| 2020 | 36.53% |